UBS Group »

Fennec Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $224k 20k 11.22
2023-09-30 $75k 10k 7.51
2023-06-30 $93k 11k 8.83
2023-03-31 $5.9k 705 8.31
2022-12-31 $614 64 9.59
2022-09-30 $48k 3.1k 15.63
2022-06-30 $0 64 0.00
2022-03-31 $0 1.1k 0.00
2021-12-31 $0 7.8k 0.00
2021-09-30 $1.0k 64 15.63
2021-06-30 $430k 59k 7.29
2021-03-31 $252k 41k 6.21
2020-12-31 $26k 3.6k 7.32
2020-06-30 $58k 6.9k 8.42
2019-12-31 $6.0k 983 6.10
2019-09-30 $11k 2.3k 4.78
2019-06-30 $0 107 0.00
2019-03-31 $2.0k 311 6.43
2018-12-31 $46k 7.2k 6.39
2018-09-30 $23k 2.8k 8.22
2018-06-30 $45k 4.3k 10.48
2017-12-31 $8.0k 813 9.84
2017-09-30 $1.0k 79 12.66